Paresthesia treatment market is anticipated to grow at a CAGR of 3.6 % during the forecast period (2023-2030). The market’s growth is attributed to high rate of chronic pain across the globe. According to the Population Health Metrics, in November 2022, about 20.0% of individuals globally suffer from chronic pain that signify an enormous expense for the medical community. Numerous chronic pain conditions, including neuropathic pain linked to paresthesia, are prevalent in the aforementioned group. Chronic pain is a widespread condition, affecting around 20% of the global population. A 2016 Global Burden of Disease Study reported that pain and pain-related diseases were the leading cause of disability and disease burden globally. The most common chronic symptom was recurrent tension-type headache, with 1.9 billion people affected. Low back and neck pain were the leading causes of disability internationally, with other types of chronic pain also featured in the top 10 disabilities.
Get Free Sample link @ https://www.omrglobal.com/request-sample/paresthesia-treatment-market
The global paresthesia treatment market is segmented on the type, treatment, and distribution channel. Based on the type, the market is sub-segmented into chronic paresthesia, and acute paresthesia. Based on the treatment, the market is sub-segmented into immunosuppressant, anticonvulsants, topical creams, antivirals, and others. Furthermore, on the basis of distribution channel, the market is sub-segmented into online retailers, hospitals and healthcare facilities, retail pharmacy, and others. The retail pharmacy subcategory is expected to capture a significant portion of the market share within the distribution channel segment. This is attributed to the rise in the number of retail pharmacies throughout the globe and simpler access to medications at the aforementioned places.
full report of Paresthesia Treatment Market available @ https://www.omrglobal.com/industry-reports/paresthesia-treatment-market
- Market Coverage
- Market number available for – 2023-2029
- Base year- 2022
- Forecast period- 2023-2029
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
- , and others
Market Segmentation
Global Paresthesia Treatment Market by Type
- Chronic Paresthesia
- Acute Paresthesia
Global Paresthesia Treatment Market by Treatment
- Immunosuppressant
- Anticonvulsants
- Topical Creams
- Antivirals
- Others (Physical Therapy, and Vitamin Deficiencies)
Global Paresthesia Treatment Market by Distribution Channel
- Online Retailers
- Hospitals and Healthcare Facilities
- Retail Pharmacy
- Others (Government Procurement, and Specialized Clinics and Pain Management Centers)
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Bio-Medical Research Ltd.
- Boston Scientific Corp.
- Cipla Ltd.
- EnteroMedics Inc.
- Forbes Media LLC
- GlaxoSmithKline
- Glenmark Pharmaceuticals Ltd.
- Medtronic Pvt Ltd.
- Merck & Co., Inc.
- Neurospine Institute
- Nevro Corp. ?
- OMRON Healthcare, Inc.
- Pfizer Inc.
- Stryker Corp.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global paresthesia treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies. Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/paresthesia-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
